Lapides Asset Management’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-72,200
Closed -$2.52M 76
2020
Q4
$2.52M Hold
72,200
1.08% 38
2020
Q3
$2.63M Hold
72,200
1.44% 27
2020
Q2
$2.71M Buy
72,200
+24,600
+52% +$984K 1.57% 25
2020
Q1
$1.75M Sell
47,600
-17,500
-27% -$680K 1.32% 28
2019
Q4
$2.64M Sell
65,100
-51,300
-44% -$1.91M 1.38% 29
2019
Q3
$4.04M Sell
116,400
-11,400
-9% -$376K 2.09% 18
2019
Q2
$4.05M Sell
127,800
-23,500
-16% -$698K 1.87% 20
2019
Q1
$4.53M Buy
151,300
+29,200
+24% +$837K 1.71% 23
2018
Q4
$3.77M Sell
122,100
-63,900
-34% -$2.33M 1.53% 26
2018
Q3
$7.05M Sell
186,000
-800
-0.4% -$30.3K 1.54% 25
2018
Q2
$7.17M Buy
186,800
+64,100
+52% +$2.16M 1.52% 24
2018
Q1
$4.14M Buy
+122,700
New +$4.71M 0.91% 42

Other funds holding PBH

Lapides Asset Management's PBH Position: Q1 2021 in Review

Lapides Asset Management sold out of Prestige Consumer Healthcare (PBH) in Q1 2021, closing a stake of 72,200 shares — an estimated $2.52M sold.

Lapides Asset Management first reported a position in PBH in Q1 2018 and held it in 12 quarters. The position peaked at $7.17M in Q2 2018. 241 funds tracked by Wall St. Rank hold PBH as of Q1 2021.

  • Lapides Asset Management reported no remaining Prestige Consumer Healthcare position as of Q1 2021 after selling out during the quarter.
  • Lapides Asset Management sold 72,200 Prestige Consumer Healthcare shares in Q1 2021, an estimated $2.52M.
  • Lapides Asset Management first reported a position in Prestige Consumer Healthcare in Q1 2018 and held it in 12 quarters.
  • Lapides Asset Management's Prestige Consumer Healthcare position peaked at $7.17M in Q2 2018.
  • 241 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2021.

Based on Lapides Asset Management's 13F filing for Q1 2021, filed 3 May 2021.